El objeto del presente pliego es la contratación de un suministro para cubrir las necesidades del laboratorio tal y como está acordado en el Proyecto de referencia con la finalidad de cumplir con todos los objetivos estipulados en él. El Proyecto de Investigación ICI20/00057 está financiado por el Instituto de Salud Carlos III (ISCIII) y cofinanciado por la Unión Europea. La prestación del suministro se realizará de acuerdo con los requerimientos y condiciones estipuladas en el Pliego de Prescri

different companies won its awards

17

of the awards went to the three most frequent winners

36%

of its calls state an estimated value

97%

Based on 22 awards with a named winner over the last 3 years. Counted by award, not by value, because lot and framework amounts are not comparable. Concentrated means the three most frequent winners took 65% or more of the awards; many suppliers, under 35% with at least ten different winners.

Spain · Medical equipment & pharmaceuticals

different companies won awards here

4,091

of the awards went to the three most frequent winners

4%

winners of the last 12 months were new here

3,545 of 3,800

buyers awarded contracts here

1,019

Based on 15,766 awards with a named winner over the last 3 years. Counted by award, not by value, because lot and framework amounts are not comparable. Concentrated means the three most frequent winners took 65% or more of the awards; many suppliers, under 35% with at least ten different winners. New: no award from the same buyer or market in the two years before.

Competition

tenders per lot on average (open and restricted procedures)

3.8

of those lots received a single tender

41%

of the awards went to companies based in another country

1%

of the tenders came from another country

1%

As the official award notices state them, over the last 3 years. Tenders per lot count open and restricted procedures only: in a negotiated procedure or a direct award a single tender is the procedure itself. The country is the one the notice gives for the winner.